Microstructured transdermal systems for intradermal vaccine and drug delivery

Pharmaceutical Technology Europe

Volumn 18, Issue 12, 2006, Pages 21-26

  Peterson, Timothy A ^a  

^a 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; SILICONE; TETANUS ANTIBODY; TETANUS TOXOID; VACCINE;

ANTIGEN PRESENTING CELL; BIOLOGICAL WARFARE; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MARKETING; DRUG QUALITY; DRUG RELEASE; DRUG STABILITY; DRUG UTILIZATION; EPIDERMIS; EQUIPMENT DESIGN; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; INJECTION SITE PAIN; LANGERHANS CELL; MASS IMMUNIZATION; MICROSTRUCTURED TRANSDERMAL SYSTEM; NEEDLE; PATIENT ATTITUDE; PATIENT COMPLIANCE; REVIEW; SHELF LIFE; SOLID STATE; STRATUM CORNEUM; TETANUS; TRANSDERMAL PATCH; VACCINATION;

EID: 33845706501     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Frost & Sullivan, Global Vaccines Markets (2005).
2. D. Ganderton and J. McAinsh, "Dressing", US Patent 3,814,097 (1974).
3. S. Henry et al., J. Pharm. Sci., 87(3), 922-925 (1998).
4. P.G. Green, J. Controlled Release, 41, 33-48 (1996).
5. S. Mitragotri, D. Blankschtein and R. Langer, Science, 269, 850-853 (1995).
6. J.A. Eppstein, H.K. Delcher and M.S. McRae, "A Clinical Feasibility Study for the Transdermal Delivery of Parathyroid Hormone 1-34 through MicroPorsTM," Proc. Int. Symp. Control. Rel. Bioact. Mater., Controlled Release Society, 26, 409 (1999).
7. A.G. Doukas and N. Kollias, Adv. Drug Del. Rev., 56(5), 559-579 (2004).
8. J.Y. Fang et al., J. Controlled Release, 100(1), 75-85 (2004).
9. D. Wirtanen, Unpublished Work (2005).
10. D.V. McAllister et al., Proceedings of the National Academy of Sciences of the United States of America, 100(24), 13755-13760 (2003).
11. Y. Tobinaga and S. Sugiyama, "Applicator for applying functional substances into human skin," US Patent Application US20050065463 A1.
12. M.S. Gerstel and V.A. Place, "Drug Delivery Device," US Patent 3,964,482 (1976).
13. J. Raeder-Devens, "Transcutaneous Vaccination Using Microstructured Transdermal Systems," SMI Controlled Release Conference (London, UK, 2005).
14. J. Wolter et al., "Antigen-Adjuvant Dose Response in a Rabbit Model Using 3M's Microstructured Transdermal System," Controlled Release Society (Miami, FL, USA, 2005).